Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Frommeyer

Showing results (61-70 of 209) with videos related to

Pageof 21
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 15, 2020
Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacingBenjamin Rath, Kevin Willy, Julian Wolfes, et al.
European Journal of Heart Failure|October 27, 2012
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failureGerrit Frommeyer, Marco Schmidt, Catharina Clauß, et al.
Frontiers in Cardiovascular Medicine|March 8, 2024
Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit heartsJulian Wolfes, Jan Uphoff, Sven Kemena, et al.
Journal of Personalized Medicine|October 23, 2021
Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation-A Prospective <sup>123</sup>I-mIBG-SPECT/CT Imaging StudyPhilipp S Lange, Christian Wenning, Nemanja Avramovic, et al.
International Journal of Cardiology|November 23, 2016
Experimental evidence for a severe proarrhythmic potential of levosimendanGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|January 31, 2017
Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
Pharmaceutics|March 27, 2025
Divergent Electrophysiologic Effects of Sacubitril in Digitalis- and Pinacidil-Related Shortened Repolarization: Experimental Evidence for Harmful Effects of Digitalis GlycosidesChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic DrugsChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
Cardiovascular Toxicology|December 6, 2018
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated HeartsChristian Ellermann, Julian Wolfes, Dirk Puckhaber, et al.
Pageof 21

Showing results (61-70 of 209) with videos related to

Sort By:
Pageof 21
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 15, 2020
Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacingBenjamin Rath, Kevin Willy, Julian Wolfes, et al.
European Journal of Heart Failure|October 27, 2012
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failureGerrit Frommeyer, Marco Schmidt, Catharina Clauß, et al.
Frontiers in Cardiovascular Medicine|March 8, 2024
Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit heartsJulian Wolfes, Jan Uphoff, Sven Kemena, et al.
Journal of Personalized Medicine|October 23, 2021
Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation-A Prospective <sup>123</sup>I-mIBG-SPECT/CT Imaging StudyPhilipp S Lange, Christian Wenning, Nemanja Avramovic, et al.
International Journal of Cardiology|November 23, 2016
Experimental evidence for a severe proarrhythmic potential of levosimendanGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|January 31, 2017
Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
Pharmaceutics|March 27, 2025
Divergent Electrophysiologic Effects of Sacubitril in Digitalis- and Pinacidil-Related Shortened Repolarization: Experimental Evidence for Harmful Effects of Digitalis GlycosidesChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic DrugsChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
Cardiovascular Toxicology|December 6, 2018
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated HeartsChristian Ellermann, Julian Wolfes, Dirk Puckhaber, et al.
Pageof 21